Home › Trial NCT05579769
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.
- Trial IDNCT05579769
- StatusTerminated
- PhasePhase 2
- Study typeInterventional
- SponsorSt. Jude Children's Research Hospital
- Enrollment3
- Start date2023-03-14
- ConditionsHematologic Malignancy · Myeloid Malignancy
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.